Stakeholders from different industries convened to discuss the roadmap ahead to become the next innovation powerhouse at ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...

AbbVie ( ABBV 0.61%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...

Simplifying regulations and updating outdated laws will enhance the ease of conducting biotech research and development, facilitating faster translation of scientific discoveries into market-ready ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...